Saijo Fumito, Mutoh Mitsuhisa, Tokumine Joho, Yoshinobu Odaka, Hama Hikaru, Namima Takashige, Shibahara Mii, Tokumura Hiromi
1 Department of Surgery, Tohoku Rosai Hospital, Sendai, Japan.
2 Department of Anesthesiology, School of Medicine, Kyorin University, Tokyo, Japan.
J Vasc Access. 2019 Sep;20(5):563-566. doi: 10.1177/1129729819834512. Epub 2019 Mar 11.
Totally implantable venous access devices are valuable tools for total parenteral nutrition, chemotherapy, and long-term intravenous therapy. However, late catheter fracture is a well-known complication of totally implantable venous access device, particularly in Groshong silicone catheter. Recently, a specific type of totally implantable venous access device made with Groshong silicone has been introduced to facilitate power injection of contrast medium for enhanced computed tomography.
We reported three cases of catheter fracture in power-injectable Groshong silicone totally implantable venous access device. From May 2012 to August 2014, 66 patients underwent power-injectable Groshong silicone totally implantable venous access device implantation at our institution, with a median follow-up of 20.1 (range 0.2-58.1) months. The catheters in all patients were inserted into the internal jugular vein under ultrasound guidance and were connected to the port implanted in the upper chest through the subcutaneous tunnel. Chemotherapy was administered using these routes. Fractures of all three cases specifically showed a torn catheter section: smooth surface on one side, and a rough edge on the other side of the catheter, suggesting that long-term repeated stretch force may be related with the mechanism of fracture.
Totally implantable venous access devices with Groshong silicone catheters, if inserted via the internal jugular vein, have a potential risk for late catheter fracture.
全植入式静脉通路装置是全胃肠外营养、化疗及长期静脉治疗的重要工具。然而,导管晚期断裂是全植入式静脉通路装置的一种常见并发症,尤其是在Groshong硅胶导管中。最近,一种采用Groshong硅胶制成的特定类型全植入式静脉通路装置被引入,以方便在增强计算机断层扫描中进行造影剂的动力注射。
我们报告了3例可进行动力注射的Groshong硅胶全植入式静脉通路装置发生导管断裂的病例。2012年5月至2014年8月,我院有66例患者接受了可进行动力注射的Groshong硅胶全植入式静脉通路装置植入术,中位随访时间为20.1(范围0.2 - 58.1)个月。所有患者的导管均在超声引导下插入颈内静脉,并通过皮下隧道与植入在上胸部的端口相连。通过这些途径进行化疗。所有3例病例的断裂均表现为导管部分撕裂:导管一侧表面光滑,另一侧边缘粗糙,提示长期反复拉伸力可能与断裂机制有关。
采用Groshong硅胶导管的全植入式静脉通路装置,如果经颈内静脉插入,存在导管晚期断裂的潜在风险。